Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

An In vitro Model of Chlamydia trachomatis Infection in Human Dendritic Cells

Version 1 : Received: 4 May 2023 / Approved: 4 May 2023 / Online: 4 May 2023 (08:57:52 CEST)

A peer-reviewed article of this Preprint also exists.

Mallonga, Z. K., Filgueira, L. (2024). An In vitro Model of Chlamydia trachomatis Infection in Human Dendritic Cells. Trans Med OA, 2(1), 01-07. Mallonga, Z. K., Filgueira, L. (2024). An In vitro Model of Chlamydia trachomatis Infection in Human Dendritic Cells. Trans Med OA, 2(1), 01-07.

Abstract

Chlamydia trachomatis (CT) is an obligate intracellular bacterial pathogen known to cause trachoma, sexually transmitted infections, and reactive arthritis. The more serious sequelae of these diseases, blindness from trachoma and pelvic inflammatory disease from chlamydial STD are immunopathological responses to chronic infections. With the abundance of dendritic cells in CT infection sites and their central importance in immune regulation, the susceptibility of dendritic cells to CT infection was investigated in vitro. CT (serovar F) was grown and extracted from HeLa 229 cells for infection of human dendritic cells (DCs). Human DCs were generated from peripheral blood mononuclear cells in the presence of GM-CSF and IL-4. Infected DCs were harvested at 0, 4, 24, and 48 h after infection and immunostained. Results from fluorescence microscopy showed that DC can be infected and can support the growth of CT in vitro. Intracellular elementary and reticulate bodies of CT were detected, and reticulate bodies were shown to multiply over the 48 h-cycle in DC. At 48 h, intracellular elementary bodies were detected in some DCs. These results may provide new insights into the possible participation of DC in sustaining chronic or latent infection, or even dissemination of CT infection to other sites.

Keywords

Chlamydia trachomatis; elementary bodies; human dendritic cells; in vitro; reticulate bodies

Subject

Biology and Life Sciences, Immunology and Microbiology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.